tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU

Neuren Pharmaceuticals Limited (NEU) Revenue

Compare
204 Followers

Neuren Pharmaceuticals Limited Revenue

Neuren Pharmaceuticals Limited had a revenue of 24.33M in the quarter ending Jun 30, 2024, with -85.61%. This bring the company's revenue in the last twelve months to 193.33M, Increased -16.64%. In the fiscal year ending Dec 31, 2023, Neuren Pharmaceuticals Limited had annual revenue of 231.93M with 1493.66% growth.
Revenue (ttm)
193.33M
Revenue Growth
-8.06%
P/S Ratio
5.28
Revenue/Employee
$28,990,625
Employees
8
Market Cap
$1.22B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023231.93M217.37M+1,493.66%
Dec 31, 202214.55M11.36M+355.21%
Dec 31, 20213.20M2.48M+345.89%
Dec 31, 2020717.00K222.00K+44.85%
Dec 31, 2019495.00K-13.49M-96.46%
Dec 31, 201813.99M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis